Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

No Thumbnail Available

Authors

Runnebaum, I. B.
Wang-Gohrke, S.
Vesprini, D.
Kreienberg, R.
Lynch, H.
Moslehi, R.
Ghadirian, P.
Weber, B.
Godwin, A. K.
Risch, H.
Show 10 more

Issue Date

2001

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Runnebaum, IB; Wang-Gohrke, S.; Vesprini, D.; Kreienberg, R.; Lynch, H.; Moslehi, R.; Ghadirian, P.; Weber, B.; Godwin, AK; Risch, H.; Garber, J.; Lerman, C.; Olopade, OI; Foulkes, WD; Karlan, B.; Warner, E.; Rosen, B.; Rebbeck, T.; Tonin, P.; Dube, MP; Kieback, DG; Narod, SA. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 2001, OCT. 11(7):635-638.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/71939

PubMed ID

11668223

DOI

ISSN

0960-314X
0960-314X

EISSN

Collections

Faculty Bibliography Database